Table 1.
Demographic and clinical characteristics of patients.
Table 2.
Stent details.
Table 3.
Procedural details.
Fig 1.
Univariate Kaplan-Meier curves for 1-year outcomes after PCI, stratified by stent type.
(A) All-cause mortality. (B) Combined outcome of death or repeat PCI in the same vessel. BMS, bare-metal stent; DES, drug-eluting stent; PCI, percutaneous coronary intervention.
Table 4.
Incidence of major outcomes after PCI with stent implantation.
Fig 2.
Absolute standardized differences in baseline characteristics, stratified according to stent type.
(Left) Before matching. (Right) After matching. BMS, bare-metal stent; DES, drug-eluting stent.
Fig 3.
Temporal trend of stent usage by stent type.
BMS, bare-metal stent; DES, drug-eluting stent.
Table 5.
Multivariable regression for propensity to receive a certain stent type.
Fig 4.
Estimated importance of predictors for 1-year outcomes after PCI.
(A) All-cause mortality. (B) Combined outcome of death or repeat PCI in the same vessel. CAD, coronary artery disease; PTCA, percutaneous transluminal coronary angioplasty.
Fig 5.
Random forest analysis of predictors of all-cause mortality at 1-year after post PCI.
CAD, coronary artery disease; TMNT, treatment; PCI, percutaneous coronary intervention.
Fig 6.
A. A linear trend was seen between the probability of death and stented length (i.e., total length of implanted stents) The risk of death increased significantly with total stented length (Fig 6A). After the age of 50 years, the risk of adverse outcomes increased significantly with age (Fig 6B). There was no difference in outcomes between BMSs and DESs wider than 4 mm (Fig 6C).